The Steroid Hormone Antagonist RU486: Mechanism at the Cellular Level and Clinical Applications
- 1 December 1991
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 20 (4) , 873-891
- https://doi.org/10.1016/s0889-8529(18)30248-2
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Voluntary Interruption of Pregnancy with Mifepristone (RU 486) and a Prostaglandin AnalogueNew England Journal of Medicine, 1990
- Regulation of gene expression by nuclear hormone receptorsCurrent Opinion in Cell Biology, 1989
- Compared intracellular localization of the glucocorticosteroid and progesterone receptors: An immunocytochemicai studyExperimental Cell Research, 1989
- The cDNA-derived amino acid sequence of chick heat shock protein Mr 90,000 (HSP 90) reveals A “DNA like” structure: Potential site of interaction with steroid receptorsBiochemical and Biophysical Research Communications, 1989
- Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNABiochemical and Biophysical Research Communications, 1987
- Termination of Early Pregnancy by the Progesterone Antagonist RU 486 (Mifepristone)New England Journal of Medicine, 1986
- Augmentation of progesterone receptor concentration by progesterone and estrogen treatments in the chick oviductJournal of Steroid Biochemistry, 1984
- RU 38486: Potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activationJournal of Steroid Biochemistry, 1984
- Monohydroxytamoxifen: An antioestrogen with high affinity for the chick oviduct oestrogen receptorBiochemical and Biophysical Research Communications, 1979
- Absence of correlation between antiestrogenic activity and binding affinity for the estrogen receptorBiochemical and Biophysical Research Communications, 1979